Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer.
XB130 is a newly characterized adaptor protein that was reported to promote thyroid tumor growth, but its role in the progression of other kinds of cancer such as gastric cancer (GC) remains unknown. Accordingly, we investigated the association between XB130 expression and the prognosis of GC patien...
Guardado en:
Autores principales: | Min Shi, Weizhen Huang, Li Lin, Dayong Zheng, Qiang Zuo, Lin Wang, Nina Wang, Yajun Wu, Yulin Liao, Wangjun Liao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc6c3a812eb9423a8ba4f290e6e5c9c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
por: Pirawan Poosekeaw, et al.
Publicado: (2021) -
Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma
por: Pirawan Poosekeaw, et al.
Publicado: (2021) -
Combined bioinformatics technology to explore pivot genes and related clinical prognosis in the development of gastric cancer
por: Jiasheng Xu, et al.
Publicado: (2021) -
Clinicopathological features and prognosis of gastric adenosquamous carcinoma
por: Fan Feng, et al.
Publicado: (2017) -
Acta No. 130
por: Banco Central de Chile
Publicado: (2019)